Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
Guided Bone Regeneration Membrane in Dental Surgery More
This TACE inhibitory protein could be used as a new therapeutic agent against chronic inflammatory diseases that are mediated by TNF-alpha. More
Prevents oral trauma to surgical or long term ventilated patients due to insertion of endotracheal tube; additionally this novel device is beneficial in endoscope labs for both bronchoscope and transesophageal echocardiogram (TEE) procedures. More
The antibody detects a protein of Candida famata and is useful for detection of candidiasis and retinopathies in samples from blood, urine, aqueous humour, vitreous humour, and cerebral spinal fluid without interference from other species of Candida More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Medical and dental uses of biocompatible nanofiber scaffolds More
The omega-3 fatty acids are extracted from New Zealand green lipped mussels and developed into oils for use in anti-inflammatory compounds by our UK based clients. More
Phase IV Clinical Development of Sinuforte (Nasodren) Nasal Spray More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Related Reports
Market Research Reports provided by reports.innovaro.com
May 2008 - 85 pages - $1,995
Jan 2011 - 15 pages - $99
Nov 2010 - 15 pages - $99
Sep 2010 - 13 pages - $99
Jul 2010 - 13 pages - $99
Aug 2010 - 25 pages - $99
Sep 2010 - 13 pages - $99
Feb 2011 - 22 pages - $99
Apr 2010 - 23 pages - $99
Oct 2010 - 25 pages - $99
Your selection
- Therapeutic target
- Oral Health del
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Aphthous ulcers
- Dental disorder (other)
- Gingivitis
- Gum disease
- Herpes simplex virus type 1 (oral)
- Mouth disorder (other)
- Mucositis oral
- Mucositis, Radiation-induced
- Periodontal disease
- Tooth decay
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us